UNLIMITED FREE ACCESS TO THE WORLD'S BEST IDEAS

SUBMIT
Already a GlobalSpec user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your GlobalSpec Experience

Finish!
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

CLSI I/LA32

Newborn Screening by Tandem Mass Spectrometry; Approved Guideline

active, Most Current
Buy Now
Organization: CLSI
Publication Date: 1 July 2010
Status: active
Page Count: 92
scope:

This document is designed to assist newborn screening laboratory personnel in the routine use of tandem mass spectrometry (MS/MS) for the detection of metabolites that may indicate certain metabolic disorders using dried blood spot (DBS) specimens. The document describes the preparation procedures for reagents, specimens, standards, and controls; calibration (both instrument and analyte); standardization; control acceptance criteria; disorder profiles (interpretation of MS/MS spectra); external effects on results (eg, transfusion and total parenteral nutrition [TPN]); result reporting; and follow-up recommendations.

Document History

CLSI I/LA32
July 1, 2010
Newborn Screening by Tandem Mass Spectrometry; Approved Guideline
This document is designed to assist newborn screening laboratory personnel in the routine use of tandem mass spectrometry (MS/MS) for the detection of metabolites that may indicate certain metabolic...

References

Advertisement